0
0

Department of Health and Human Services Awarded a Contract to DYNPORT VACCINE COMPANY LLC for $90,000,000.00

Signed on

12/15/2014, 12:00 AM

DYNPORT VACCINE COMPANY LLC Government Contract #HHSN272201500005I

DYNPORT VACCINE COMPANY LLC was awarded a contract with the United States Government for $90,000,000.00. The contract was awarded by the agency office NATIONAL INSTITUTES OF HEALTH NIAID, which is a division with the National Institutes of Health within the Department of Health and Human Services.

Summary of Award

The recipient of the federal contract is DynPort Vaccine Company LLC, a U.S.-owned business located in Frederick, Maryland. The contract, funded by the National Institutes of Health, is for a Phase 1 clinical trial unit for therapeutics against infectious diseases. It is valued at $90,000,000. Notable officers involved in the contract include Amy Gilliland, Paul Nedzbala, and others. No transactions were listed.

Contract Details

Contract IDHHSN272201500005I
Contract TypeIDV_B_B
Total Obligation$0.00
Exercised Options$0.00
Base Amount + Options$90,000,000.00
Date Signed2014-12-15
Contract DescriptionIGF::OT::IGF AWARD OF PHASE 1 CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES, IDIQ CONTRACT. PERIOD OF PERFORMANCE: DECEMBER 15, 2014 THROUGH DECEMBER 14, 2021.
Start Date2014-12-15
End Date2024-12-14

Agency Details

Awarding AgencyDepartment of Health and Human Services
Awarding Sub AgencyNational Institutes of Health
Awarding OfficeNATIONAL INSTITUTES OF HEALTH NIAID
Funding AgencyDepartment of Health and Human Services
Funding Sub AgencyNational Institutes of Health
Funding OfficeNATIONAL INSTITUTES OF HEALTH NIAID

Recipient Details

RecipientDYNPORT VACCINE COMPANY LLC
Recipient Location64 THOMAS JOHNSON DR FREDERICK MARYLAND, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Limited Liability Corporation, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions